richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine. .
we�re at the beginning of a new breakout level of truth. it�s called independent media. .
1243 Used Today
318 Used Today
77 Used Today
110 Used Today
38 Used Today
273 Used Today
323 Used Today
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine. .
we�re at the beginning of a new breakout level of truth. it�s called independent media. .
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.” . .
the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010. .
stephen silberstein, md, director, jefferson university headache center. .
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened.
218 Used Today
181 Used Today